» Articles » PMID: 16950977

Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and Treatment

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2006 Sep 5
PMID 16950977
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Infantile hemangiomas are the most common tumor of infancy. Risk factors for complications and need for treatment have not been studied previously in a large prospective study. This study aims to identify clinical characteristics associated with complications and the need for therapeutic intervention.

Patients And Methods: We conducted a prospective cohort study at 7 US pediatric dermatology clinics with a consecutive sample of 1058 children, aged < or = 12 years, with infantile hemangiomas enrolled between September 2002 and October 2003. A standardized questionnaire was used to collect data on each patient and each hemangioma, including clinical characteristics, complications, and treatment.

Results: Twenty-four percent of patients experienced complications related to their hemangioma(s), and 38% of our patients received some form of treatment during the study period. Hemangiomas that had complications and required treatment were larger and more likely to be located on the face. Segmental hemangiomas were 11 times more likely to experience complications and 8 times more likely to receive treatment than localized hemangiomas, even when controlled for size.

Conclusions: Large size, facial location, and/or segmental morphology are the most important predictors of poor short-term outcomes as measured by complication and treatment rates.

Citing Articles

The Evaluation, Diagnosis, and Management of Infantile Hemangiomas-A Comprehensive Review.

Resic A, Barcot Z, Habek D, Pogorelic Z, Baskovic M J Clin Med. 2025; 14(2).

PMID: 39860430 PMC: 11765582. DOI: 10.3390/jcm14020425.


Optimizing Propranolol Therapy for Infantile Hemangiomas: The Role of the Multidisciplinary Team.

Yasuda-Koiwa M, Ogawa T, Ogawa A, Takizawa F, Mukoyama Y, Moriguchi S Cureus. 2025; 16(12):e75806.

PMID: 39822455 PMC: 11735240. DOI: 10.7759/cureus.75806.


Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation.

Lu W, Yang Z, Wang M, Zhang Y, Qi Z, Yang X Drug Des Devel Ther. 2024; 18:4065-4088.

PMID: 39286286 PMC: 11404501. DOI: 10.2147/DDDT.S460575.


Therapeutic evaluation of electrochemical therapy combined with local injection of pingyangmycin for the treatment of venous malformations in the tongue.

Yuan W, Wang X Front Neurol. 2024; 15:1425395.

PMID: 39233678 PMC: 11371561. DOI: 10.3389/fneur.2024.1425395.


Infantile Hemangioma with Minimal or Arrested Growth (IHMAG): A Retrospective Analysis of Clinical and Dermoscopic Diagnostic Clues.

Neri I, Orioni G, Leuzzi M, Facchini E, Mengozzi E, Chessa M Dermatol Pract Concept. 2024; 14(3).

PMID: 39122516 PMC: 11313902. DOI: 10.5826/dpc.1403a206.